reveromycin a has been researched along with prodigiosin in 1 studies
| Studies (reveromycin a) | Trials (reveromycin a) | Recent Studies (post-2010) (reveromycin a) | Studies (prodigiosin) | Trials (prodigiosin) | Recent Studies (post-2010) (prodigiosin) |
|---|---|---|---|---|---|
| 43 | 0 | 19 | 747 | 3 | 321 |
| Protein | Taxonomy | reveromycin a (IC50) | prodigiosin (IC50) |
|---|---|---|---|
| Low molecular weight protein-tyrosine phosphatase A | Mycobacterium tuberculosis H37Rv | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, BY; Nagai, K; Teruya, T; Woo, JT; Yonezawa, T | 1 |
1 review(s) available for reveromycin a and prodigiosin
| Article | Year |
|---|---|
Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
Topics: Animals; Apoptosis; Bacteria; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Cell Survival; Cyclosporine; Depsipeptides; Fungi; Heterocyclic Compounds, 3-Ring; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoclasts; Prodigiosin; Pyrans; Spiro Compounds; Tacrolimus | 2008 |